DME AND KELGREN LWARENCE LEVEL 3-4 SUCESS POSSIBLE BREAKOUT

26. Juni 2014

TWO BIG BANKS HAVE COME IN FOR SUPPORT AND IN THIS CASE HEAVY VOLUME OCCURRED WITH MINOR NEWS AWAITING THE PHASE THERE PIVOTAL STUDY WITH ITS OSTEOARTHRITIS DRUG AMPION SHOWING MAJOR STRENGTH, BUT HEAVY VOLUME COMPARED TO 30 DAY LEADS TO BELIEVE THAT THE 30 DAY SUPPORT WILL NOT BE BROKEN AND WITH SUCCESSFUL COMPLETION OF THE CARTRIDGE REGROWTH PACKAGE NAMED "KNEE REPAIR KIT" COMING SOON THIS STOCK IS BUILDING MOMENTUM.... JEFFRIES AND CITI TOOK MAJOR INTERESTS AND CREATOR OF AMPION FLAGSHIP DRUG TAKES MAJORITY OF PAY IN STOCK.... THAT IS MOST BULLISH THING I CAN SAY!